- Home
- NAGE vs AOD Comparison
NAGE vs AOD Comparison
Compare NAGE & AOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAGE
- AOD
- Stock Information
- Founded
- NAGE 1999
- AOD 2006
- Country
- NAGE United States
- AOD United Kingdom
- Employees
- NAGE N/A
- AOD N/A
- Industry
- NAGE Medicinal Chemicals and Botanical Products
- AOD Investment Managers
- Sector
- NAGE Health Care
- AOD Finance
- Exchange
- NAGE Nasdaq
- AOD Nasdaq
- Market Cap
- NAGE 861.0M
- AOD 862.4M
- IPO Year
- NAGE N/A
- AOD N/A
- Fundamental
- Price
- NAGE $9.04
- AOD $8.79
- Analyst Decision
- NAGE Strong Buy
- AOD
- Analyst Count
- NAGE 3
- AOD 0
- Target Price
- NAGE $16.67
- AOD N/A
- AVG Volume (30 Days)
- NAGE 1.2M
- AOD 423.5K
- Earning Date
- NAGE 08-06-2025
- AOD 01-01-0001
- Dividend Yield
- NAGE N/A
- AOD 12.95%
- EPS Growth
- NAGE N/A
- AOD 213.63
- EPS
- NAGE 0.18
- AOD 1.93
- Revenue
- NAGE $107,925,000.00
- AOD $72,962,082.00
- Revenue This Year
- NAGE $26.44
- AOD N/A
- Revenue Next Year
- NAGE $20.06
- AOD N/A
- P/E Ratio
- NAGE $50.51
- AOD $4.44
- Revenue Growth
- NAGE 29.77
- AOD N/A
- 52 Week Low
- NAGE $2.53
- AOD $6.99
- 52 Week High
- NAGE $14.69
- AOD $9.14
- Technical
- Relative Strength Index (RSI)
- NAGE N/A
- AOD 40.98
- Support Level
- NAGE N/A
- AOD $8.91
- Resistance Level
- NAGE N/A
- AOD $9.05
- Average True Range (ATR)
- NAGE 0.00
- AOD 0.09
- MACD
- NAGE 0.00
- AOD -0.03
- Stochastic Oscillator
- NAGE 0.00
- AOD 4.03
About NAGE Niagen Bioscience Inc. Common Stock
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
About AOD abrdn Total Dynamic Dividend Fund of Beneficial Interest
Aberdeen Total Dynamic Dividend Fund is a diversified, closed-end management investment company. Its investment objective is to seek high current dividend income. The company also focuses on the long-term growth of capital as a secondary investment objective. The fund invests in foreign securities, including direct investments in securities of foreign issuers and investments in depositary receipts that represent indirect interests in securities of foreign issuers. Its portfolio consists of securities from Information Technology, Financial, Healthcare, and Industrials among other sectors.